/other/Diamyd_Medical_AB_publ-logo.png?Expires=1750047010&Signature=JglbxnVLswTu3K8p1YDT6TLJRKs5CCgkmuDH6kf~4IuSE7ouTK3QNl5UfVYVhardug40176oBxlti~8M0nMimJRjuCywwl7aDB8YXM4JO4Bfc-hXlqJgwBDVdOEl6y11G-sGUk7jRAx~WsrGNsEPtc4eGxKaMHBowvVMu0wQ59DyasEvkr1sTxi4pMN00fMQayJT1b3AaCwYACfArtwAVgl-1gbRVhEQuXk8t1ThvDISVKELrzMw1QD89207sYe5DW2lzy9uZPcsJgbVxG42a64AZlyLFXZu-Wytg8Q9mJmlFOJo8SLkSxl6-F9uzq6TSeilaTg02OniP3U2WkHFiA__&Key-Pair-Id=K6QMJA61RGOXQ){kind=logo}
Diamyd Medical AB (publ)
DMYD | FN
Overview
Corporate Details
- ISIN(s):
- SE0005162872 (+5 more)
- LEI:
- 5493003NP2HNQDEKB804
- Country:
- Sweden
- Address:
- BOX 7349, 103 90 STOCKHOLM
- Website:
- N/A
- Sector:
- Health Care
- Industry:
- Biotechnology
Description
Diamyd Medical AB is a biotech company working on precision medicine for autoimmune diabetes. They are developing antigen-specific immunotherapies.
Financials & KPIs
No data available
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Chat, Summarize & Extract with AI!
You have of free filing views remaining.
Upgrade for unlimited access.
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| No filings match the current criteria. | ||||
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
Nykode Therapeutics ASA | Norway | NYKD | |
|
Oculis Holding AG | Switzerland | OCS | |
|
ONCODESIGN | France | ALONC | |
|
Oncodesign Precision Medicine S.A | France | ALOPM | |
|
Oncoinvent ASA | Norway | OCIN | |
|
Oncopeptides | Sweden | ONCO | |
|
Onxeo | France | ALONX | |
|
OPKO Health Inc. | Israel | OPK | |
|
Oramed Pharmaceuticals Inc. | Israel | ORMP | |
|
Oryzon Genomics S.A. | Spain | ORY |